SELL
SELLAS Life Sciences files Underwriting Agreement
SELLAS Life Sciences Group filed a prospectus to initially sell 11.5M shares of common stock, with underwriters J.P. Morgan and TD Securities, while also reserving options to sell up to 1.7M additional shares.